MedTrace Logo

Podocyturia as Predictive Factor for Pre-eclampsia

NCT03316430 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-01-12

No results posted yet for this study

Summary

Pre-eclampsia is an hypertensive disorder appearing during pregnancy, inducing serious maternal, fetal and neonatal mortality and morbidity. Podocyn could be identified in the urine, before proteinuria, a key element in the diagnostic of pre-eclampsia. Preventive treatment using aspirin could be administrated in early pregnancy. We hypothesized that podocyturia could be an early indicator of preeclampsia. This is a prospective, non-interventional, monocentric study.

Conditions

  • Pre-Eclampsia

Interventions

OTHER

Podocyturia quantification

Podocyturia quantification at first planned prenatal care visit before 16 weeks of gestation

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-15
Primary Completion
2021-12-07
Completion
2021-12-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03316430 on ClinicalTrials.gov